Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.

Cell Reports
Andrea J PruijssersTimothy P Sheahan

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the novel viral disease COVID-19. With no approved therapies, this pandemic illustrates the urgent need for broad-spectrum antiviral countermeasures against SARS-CoV-2 and future emerging CoVs. We report that remdesivir (RDV) potently inhibits SARS-CoV-2 replication in human lung cells and primary human airway epithelial cultures (EC50 = 0.01 μM). Weaker activity is observed in Vero E6 cells (EC50 = 1.65 μM) because of their low capacity to metabolize RDV. To rapidly evaluate in vivo efficacy, we engineered a chimeric SARS-CoV encoding the viral target of RDV, the RNA-dependent RNA polymerase of SARS-CoV-2. In mice infected with the chimeric virus, therapeutic RDV administration diminishes lung viral load and improves pulmonary function compared with vehicle-treated animals. These data demonstrate that RDV is potently active against SARS-CoV-2 in vitro and in vivo, supporting its further clinical testing for treatment of COVID-19.

References

Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Boyd YountRalph S Baric
Mar 17, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Moira Chan-Yeung, Rui-Heng Xu
Oct 23, 2004·Emerging Infectious Diseases·I F N HungK Y Yuen
Dec 4, 2004·Nature Medicine·J S M PeirisK Y Yuen
Dec 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peng Gong, Olve B Peersen
Mar 27, 2012·Bioorganic & Medicinal Chemistry Letters·Aesop ChoChoung U Kim
Apr 19, 2012·Expert Opinion on Drug Metabolism & Toxicology·Christopher A KoczorWilliam Lewis
Sep 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Trevor ScobeyRalph S Baric
Jun 27, 2015·PloS One·Vineet D MenacheryMartin T Ferris
Nov 10, 2015·Nature Medicine·Vineet D MenacheryRalph S Baric
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Vineet D MenacheryRalph S Baric
Jun 28, 2016·Nature Reviews. Microbiology·Emmie de WitVincent J Munster
Feb 9, 2017·The New England Journal of Medicine·Yaseen M ArabiRobert A Fowler
Mar 7, 2017·Scientific Reports·Michael K LoChristina F Spiropoulou
Apr 7, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Yuelong Shu, John McCauley
Jul 1, 2017·Science Translational Medicine·Timothy P SheahanRalph S Baric
Aug 10, 2017·Journal of Medicinal Chemistry·Youcef MehellouJan Balzarini
Sep 16, 2017·Antiviral Research·Noreen MumtazJeroen J A van Kampen
May 30, 2019·Nature Communications·Robert N Kirchdoerfer, Andrew B Ward
Jan 10, 2017·Global Challenges·Stefan Elbe, Gemma Buckland-Merrett
Nov 28, 2019·The New England Journal of Medicine·Sabue MulanguUNKNOWN PALM Consortium Study Team
Feb 1, 2020·The New England Journal of Medicine·Michelle L HolshueUNKNOWN Washington State 2019-nCoV Case Investigation Team
Feb 15, 2020·Proceedings of the National Academy of Sciences of the United States of America·Emmie de WitHeinz Feldmann
Feb 28, 2020·The Lancet Infectious Diseases·Yang PanQuanyi Wang
Mar 12, 2020·Emerging Infectious Diseases·Jennifer HarcourtNatalie J Thornburg
Mar 25, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Li RunfengYang Zifeng
Apr 3, 2020·Nature·Roman WölfelClemens Wendtner
Apr 11, 2020·The New England Journal of Medicine·Jonathan GreinTimothy Flanigan
Apr 14, 2020·JAMA : the Journal of the American Medical Association·James M SandersJames B Cutrell

❮ Previous
Next ❯

Citations

Aug 7, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Julie A Bastarache
Aug 28, 2020·The EMBO Journal·Theresa KlemmDavid Komander
Sep 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gustavo R Villas-BoasSilvia A Oesterreich
Aug 6, 2020·Nature Structural & Molecular Biology·Matthew McCallumDavid Veesler
Oct 6, 2020·Anesthesiology·George W WilliamsHolger K Eltzschig
Oct 13, 2020·SLAS Discovery·Emery SmithTimothy P Spicer
Oct 14, 2020·Proceedings of the National Academy of Sciences of the United States of America·Caitlin E EdwardsRalph S Baric
Oct 9, 2020·Proceedings of the National Academy of Sciences of the United States of America·Michael K LoChristina F Spiropoulou
Oct 28, 2020·Pharmaceutics·Sawittree SahakijpijarnRobert O Williams Iii
Oct 9, 2020·Chembiochem : a European Journal of Chemical Biology·Obireddy Sreekanth Reddy, Wing-Fu Lai
Sep 30, 2020·Antimicrobial Agents and Chemotherapy·Minh Patrick LêGilles Peytavin
Sep 30, 2020·Antimicrobial Agents and Chemotherapy·Victoria C Yan, Florian L Muller
Nov 20, 2020·Journal of Drug Targeting·Ghazaleh Jamalipour Soufi, Siavash Iravani
Dec 4, 2020·Microorganisms·Matteo GasbarriValeria Cagno
Dec 11, 2020·Antiviral Chemistry & Chemotherapy·Johanna Huchting
Oct 31, 2020·Antimicrobial Agents and Chemotherapy·Keivan ZandiRaymond F Schinazi
Jan 14, 2021·Nature Communications·Goran KokicPatrick Cramer
Jan 14, 2021·The Biochemical Journal·George M Burslem
Nov 21, 2020·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Vladislav IzdaAmr H Sawalha
Nov 25, 2020·Antimicrobial Agents and Chemotherapy·Yili XuJoy Y Feng
Jan 20, 2021·Veterinary Research Communications·Beatriz do ValeAna Cláudia Coelho
Jan 27, 2021·Cells·Rameswari Chilamakuri, Saurabh Agarwal
Jan 22, 2021·Expert Opinion on Therapeutic Patents·Ilaria VicentiFrancesco Saladini
Dec 10, 2020·CPT: Pharmacometrics & Systems Pharmacology·Patrick O HanafinGauri G Rao
Feb 2, 2021·Journal of Medicinal Chemistry·Yingjun LiXumu Zhang
Feb 11, 2021·Journal of Biomolecular Structure & Dynamics·N R JenaHemant Kumar Srivastava
Oct 30, 2020·Risk Management and Healthcare Policy·Azadeh Teimury, Elahe Mahmoodi Khaledi
Jan 8, 2021·Global Health & Medicine·Robert W Shafer
Jan 15, 2021·Clinical Microbiology Reviews·Aleksandra SynowiecKrzysztof Pyrc
Feb 8, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Annoor AwadasseidWen Zhang
Jan 4, 2021·Biochemical and Biophysical Research Communications·M Gabriella Santoro, Ernesto Carafoli
Feb 27, 2021·Science·Jason P Wong, Blossom Damania
Mar 12, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Elad GoldbergAmir Shlomai

❮ Previous
Next ❯

Datasets Mentioned

BETA
MN985325.1
MT123290.1
and

Methods Mentioned

BETA
transgenic
bronchoalveolar
lavage
Assay
FCS
X-ray
PCR
in vitro transcription

Software Mentioned

Prime
CLC Workbench (
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.